Derivados de piridina sustituidos heterocíclicos y agentes anti-fúngicos que los contienen

Un compuesto o una sal farmacéuticamente aceptable del mismo, seleccionándose el compuesto del grupo que consiste en 3-(3-(4-(piridin 5 -2-iloximetil)-bencil)-isoxazol-5-il)-piridin-2-ilamina; 3-(3-(4-(piridin-2-ilmetoxi)-bencil)-isoxazol-5-il)-piridin-2-ilamina; 3-(3-(4-(piridin-2-iloximetil)-benci...

Full description

Saved in:
Bibliographic Details
Main Authors MATSUKURA, MASAYUKI, TANAKA, KEIGO, MURAI, NORIO, INOUE, SATOSHI, SHIROTORI, SHUJI, NAKAMOTO, KAZUTAKA, ABE, SHINYA
Format Patent
LanguageSpanish
Published 03.11.2014
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Un compuesto o una sal farmacéuticamente aceptable del mismo, seleccionándose el compuesto del grupo que consiste en 3-(3-(4-(piridin 5 -2-iloximetil)-bencil)-isoxazol-5-il)-piridin-2-ilamina; 3-(3-(4-(piridin-2-ilmetoxi)-bencil)-isoxazol-5-il)-piridin-2-ilamina; 3-(3-(4-(piridin-2-iloximetil)-bencil)-isoxazol-5-il)-piridina-2,6-diamina; 3-(3-(6-benciloxi-piridin-3-ilmetil)-isoxazol-5-il)-piridin-2,6-diamina; y 3-(1-(4-(piridin-2-iloximetil)-bencil)-1H-pìrazol-4-il)-piridina-2-ilamina. An object of the present invention is to provide an antifungal agent which has excellent antifungal effects and is superior in terms of its physical properties, safety and metabolic stability. According to the present invention, there is disclosed a compound or a pharmaceutically acceptable salt thereof, the compound being selected from the group consisting of 3-(3-(4-(pyridin-2-yloxymethyl)-benzyl)-isoxazol-5-yl)-pyridin-2-ylamine; 3-(3-(4-(Pyridin-2-ylmethoxy)-benzyl)-isoxazol-5-yl)-pyridin-2-ylamine; 3-(3-(4-pyridin-2-yloxymethyl)-benzyl)-isoxazol-5-yl)-pyridine-2,6-diamine; 3-(3-(6-benzyloxy-pyridin-3-ylmethyl)-isoxazol-5-yl)-pyridin-2,6-diamine; and 3-(1-(4-(pyridin-2-yloxymethyl)-benzyl)-1H-pyrazol-4-yl)-pyridin-2-ylamine.
AbstractList Un compuesto o una sal farmacéuticamente aceptable del mismo, seleccionándose el compuesto del grupo que consiste en 3-(3-(4-(piridin 5 -2-iloximetil)-bencil)-isoxazol-5-il)-piridin-2-ilamina; 3-(3-(4-(piridin-2-ilmetoxi)-bencil)-isoxazol-5-il)-piridin-2-ilamina; 3-(3-(4-(piridin-2-iloximetil)-bencil)-isoxazol-5-il)-piridina-2,6-diamina; 3-(3-(6-benciloxi-piridin-3-ilmetil)-isoxazol-5-il)-piridin-2,6-diamina; y 3-(1-(4-(piridin-2-iloximetil)-bencil)-1H-pìrazol-4-il)-piridina-2-ilamina. An object of the present invention is to provide an antifungal agent which has excellent antifungal effects and is superior in terms of its physical properties, safety and metabolic stability. According to the present invention, there is disclosed a compound or a pharmaceutically acceptable salt thereof, the compound being selected from the group consisting of 3-(3-(4-(pyridin-2-yloxymethyl)-benzyl)-isoxazol-5-yl)-pyridin-2-ylamine; 3-(3-(4-(Pyridin-2-ylmethoxy)-benzyl)-isoxazol-5-yl)-pyridin-2-ylamine; 3-(3-(4-pyridin-2-yloxymethyl)-benzyl)-isoxazol-5-yl)-pyridine-2,6-diamine; 3-(3-(6-benzyloxy-pyridin-3-ylmethyl)-isoxazol-5-yl)-pyridin-2,6-diamine; and 3-(1-(4-(pyridin-2-yloxymethyl)-benzyl)-1H-pyrazol-4-yl)-pyridin-2-ylamine.
Author ABE, SHINYA
NAKAMOTO, KAZUTAKA
MURAI, NORIO
MATSUKURA, MASAYUKI
INOUE, SATOSHI
SHIROTORI, SHUJI
TANAKA, KEIGO
Author_xml – fullname: MATSUKURA, MASAYUKI
– fullname: TANAKA, KEIGO
– fullname: MURAI, NORIO
– fullname: INOUE, SATOSHI
– fullname: SHIROTORI, SHUJI
– fullname: NAKAMOTO, KAZUTAKA
– fullname: ABE, SHINYA
BookMark eNrjYmDJy89L5WSIcUktyixLTMkvVkhJVSjILMpMycxLVCguLS7JLCnNBIlnpJakFuUnH16bnJOZDORXKiSmp-aVpBYrJOaVZOqmHd6Vlw6WKCxNVcgB0sn5QPHUvNQ8HgbWtMSc4lReKM3NoOjmGuLsoZtakB-fWlyQmAxUVRLvGmxkamhuamQYEmJsTIwaAAtmQA0
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
ExternalDocumentID ES2517521TT3
GroupedDBID EVB
ID FETCH-epo_espacenet_ES2517521TT33
IEDL.DBID EVB
IngestDate Fri Jul 19 14:36:40 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language Spanish
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_ES2517521TT33
Notes Application Number: ES20120193373T
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20141103&DB=EPODOC&CC=ES&NR=2517521T3
ParticipantIDs epo_espacenet_ES2517521TT3
PublicationCentury 2000
PublicationDate 20141103
PublicationDateYYYYMMDD 2014-11-03
PublicationDate_xml – month: 11
  year: 2014
  text: 20141103
  day: 03
PublicationDecade 2010
PublicationYear 2014
RelatedCompanies EISAI R&D MANAGEMENT CO., LTD
RelatedCompanies_xml – name: EISAI R&D MANAGEMENT CO., LTD
Score 2.8268661
Snippet Un compuesto o una sal farmacéuticamente aceptable del mismo, seleccionándose el compuesto del grupo que consiste en 3-(3-(4-(piridin 5...
SourceID epo
SourceType Open Access Repository
SubjectTerms CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title Derivados de piridina sustituidos heterocíclicos y agentes anti-fúngicos que los contienen
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20141103&DB=EPODOC&locale=&CC=ES&NR=2517521T3
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1NS8NAEB1qFfWmVdH6wQrSW5C42zQ9BKFJShH6gUbpQSibzUYDkpQmVfxR_gGv_WPOLol60VOSXRiyj0zeZGfeBOBCKL2iGVtGO2LCYOEVM7oqyWtTZkvOTCksJXAejqzBPbuZtqc1SCotjO4T-qabI6JHCfT3Qr-v5z-bWJ6urcwvwwSHsut-4Hit8uvYZMhmtOX1HH8y9sZuy3UdDKpGt47qzIVMFdA1WFdRtGqz7z_0lChl_ptR-juwMUFjabELNZk3YMutfrzWgM1hme_G09L18j149PBZeeVRlpNIknmySJB1OMmXOtmfqPFnVdqSidWHwEXg9TvhSjglc4LwJUa8-kyf9ARyAXnBo6pTR_sy3Yfzvh-4AwNvc_YNycy_qxYUUHoA9TRL5SEQyaXNJcZYHWTtbmzbYSw7CHfbjsyQC3oEzb_tNP-bPIZtBa9W4dETqBeLpTxFOi7CMw3kFzFIk2I
link.rule.ids 230,309,786,891,25594,76903
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1NS8NAEB1qFetNq6L1awXpLUjcTZsegtCkpWq_0Cg9CGWz2WhAktKkij_KP-C1f8zZpVUvekqyC0P2kcnbycybAJwJpVc0o5phhUwYLLhgRkMleW3KbMmZKUVNCZx7_Vrnnl2PrFEB4qUWRvcJfdPNEdGjBPp7rt_Xk5-PWJ6urczOgxiH0su273jVRXRsMmQzWvWaTms48AZu1XUd3FT1bx3VmQuZyqcrsFrHiFBHSg9NJUqZ_GaU9iasDdFYkm9BQWZlKLnLH6-VYb23yHfj6cL1sm149PBZeeVhmpFQkkk8jZF1OMlmOtkfq_FnVdqSivmHwEXg9TvhSjglM4LwxUY0_0ye9ARyAXnBo6pTR_sy2YHTdst3Owbe5vgbknHrbrkgn9JdKCZpIveASC5tLnGPVUfWbkS2HUSyjnBbdmgGXNB9qPxtp_Lf5AmUOn6vO-5e9W8OYENBrRV59BCK-XQmj5Ca8-BYg_oFO1WWTA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Derivados+de+piridina+sustituidos+heteroc%C3%ADclicos+y+agentes+anti-f%C3%BAngicos+que+los+contienen&rft.inventor=MATSUKURA%2C+MASAYUKI&rft.inventor=TANAKA%2C+KEIGO&rft.inventor=MURAI%2C+NORIO&rft.inventor=INOUE%2C+SATOSHI&rft.inventor=SHIROTORI%2C+SHUJI&rft.inventor=NAKAMOTO%2C+KAZUTAKA&rft.inventor=ABE%2C+SHINYA&rft.date=2014-11-03&rft.externalDBID=T3&rft.externalDocID=ES2517521TT3